argenx SE is a biopharmaceutical company that focuses on discovering and developing innovative antibody-based therapies for the treatment of severe autoimmune diseases and cancer. With a strong pipeline and a unique antibody engineering platform, argenx is poised for growth in the rapidly advancing field of biotechnology.
